Page 5,647«..1020..5,6465,6475,6485,649..5,6605,670..»

U of U unveils state of the art stroke treatment rooms – Video

Posted: Published on February 27th, 2013

U of U unveils state of the art stroke treatment rooms By: Noah Bond … Continue reading

Comments Off on U of U unveils state of the art stroke treatment rooms – Video

B vitamins may not help after stroke

Posted: Published on February 27th, 2013

Published: Feb. 26, 2013 at 10:54 PM HONOLULU, Feb. 26 (UPI) -- Taking B vitamins daily may not prevent cognitive decline in people who have had a stroke or transient ischemic attack, U.S. researchers say. Stroke is associated with an increased risk of cognitive decline and impairment, and the deterioration of cognitive functions such as memory or thought processing. Researchers studied whether treatment with B vitamins would help prevent cognitive decline following a stroke. More than 8,000 recent survivors of strokes or transient ischemic attacks, also called mini-strokes, were randomly assigned to take either a B vitamin pill consisting of 2 milligrams of folic acid, 25 milligrams of B6 and 500 micrograms of B12, or a placebo daily. About 2,200 patients took a mini-mental state test of their cognition at the study's start and every six months after for a median of 2.8 years. The study found no notable difference in the incidences of cognitive decline or impairment among participants taking B vitamins compared with the placebo. The findings were presented at the American Stroke Association's International Stroke Conference in Honolulu. Continued here: B vitamins may not help after stroke … Continue reading

Comments Off on B vitamins may not help after stroke

Gum disease treatment can lower annual medical costs for people with heart disease and stroke

Posted: Published on February 27th, 2013

HARRISBURG, Pa., Feb. 26, 2013 /PRNewswire/ --The latest findings from a landmark oral health study by United Concordia and Highmark Inc. show that annual medical costs are lower by $2,956 and $1,029 for individuals with heart disease or cerebrovascular disease (stroke), respectively, who are treated for gum disease. (Photo: http://photos.prnewswire.com/prnh/20130226/PH65641 ) "Once again, our UCWellnessSM study findings highlight the important role good oral health plays in overall health," said James Bramson, D.D.S., chief dental officer for United Concordia. "Treating chronic health conditions like heart disease and stroke comes with a very high health care cost; dental disease is preventable or treatable at a much lower cost and the beneficial effects through reduced health care costs are significant." Last March, United Concordia released the first round of study findings that showed annual reductions in medical costs, hospitalizations and physician visits are possible for individuals with diabetes who received treatment and ongoing maintenance for gum disease. In November, the dental carrier released a second round of findings that revealed individuals with diabetes, who are treated at least seven times for gum disease, can also realize reduced pharmaceutical costs. "Both sets of findings clearly demonstrate that treating an individual with diabetes who has … Continue reading

Comments Off on Gum disease treatment can lower annual medical costs for people with heart disease and stroke

Patient calls for specialist stroke treatment to stay in Basildon

Posted: Published on February 27th, 2013

Patient calls for specialist stroke treatment to stay in Basildon 12:00pm Monday 25th February 2013 in News By Luke Lambert A PATIENT wants to see specialist stroke treatment retained at Basildon Hospital after news it would be scaled back. It was announced yesterday that Basildon could see its stroke care reduced under plans to focus care at stroke units in Southend, Colchester and Chelmsford. These units would give all of Essex patients access to stroke specialists 24 hours a day, seven days a week with patients taken to one of the three centres for critical care within the first three crucial days of having a stroke. However, Basildon Hospital bosses and now a former stroke patient have criticised the plans to scale back the service in Basildon. Frank Doyle suffered a stroke in June 2011 and believes he may not have survived if he hadnt first been taken Basildon Hospital. Mr Doyle, 68, from Middle Crockerford, Vange said: The hospital were terrific. They looked after me from the minute I arrived to the minute I left and to see the service leave the borough would be very sad." Yesterday a hospital spokesman said: "Basildon and Thurrock University Hospitals NHS Foundation … Continue reading

Comments Off on Patient calls for specialist stroke treatment to stay in Basildon

Kessler Foundation named site for major study of wheelchair use in spinal cord injury

Posted: Published on February 27th, 2013

Public release date: 26-Feb-2013 [ | E-mail | Share ] Contact: Carolann Murphy CMurphy@KesslerFoundation.org 973-324-8382 Kessler Foundation West Orange, NJ. February 26, 2013. Kessler Foundation is participating in the Collaboration on Mobility Training (COMIT), a large study designed to maximize independence among wheelchair users with spinal cord injury (SCI). The COMIT, a SCI Model Systems (SCIMS) Multisite Collaborative Research Project, is funded by the National Institute on Disability & Rehabilitation Research (NIDRR grant #H133A120004). The 5-year, $4.5 million grant was awarded to the lead center, University of Pittsburgh Medical Center (UPMC), with Kessler Foundation receiving $850,000 as one of the collaborating sites. All four collaborating sites are participants in the NIDRR-funded SCIMS program, a network of 14 centers that studies the course of recovery and outcomes following the delivery of a coordinated system of care for individuals with SCI. The sites are: Northern New Jersey Spinal Cord Injury System (NNJSCIS) (a cooperative effort of Kessler Foundation, Kessler Institute for Rehabilitation and University of Medicine & Dentristry of NJ); the Midwest Regional Spinal Cord Injury Care System (Northwestern University's Feinberg School of Medicine, Northwestern Memorial Hospital, and Rehabilitation Institute of Chicago); and the South Florida SCI System (University of Miami Miller … Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on Kessler Foundation named site for major study of wheelchair use in spinal cord injury

Io Therapeutics, Inc. Announces Collaboration With The Michael J. Fox Foundation for Parkinson's Research for …

Posted: Published on February 27th, 2013

SANTA ANA, CA--(Marketwire - Feb 26, 2013) - Io Therapeutics, Inc. announced today the initiation of a collaboration with The Michael J. Fox Foundation for Parkinson's Research (MJFF) to evaluate the Company's experimental Retinoid X Receptor (RXR) agonist compound IRX4204 as a potential treatment for Parkinson's disease.The collaboration, funded by MJFF, will examine the effects of IRX4204 in preclinical models of Parkinson's disease. If the results are promising, these preclinical studies could lead to the initiation of a clinical trial of IRX4204 in patients with Parkinson's disease. About RXR in Parkinson's disease and IRX4204 "It was reported in the medical literature nearly a decade ago that signaling through RXR pathways promotes survival of dopaminergic neurons, the primary type of cell being destroyed in Parkinson's disease," said Dr. Rosh Chandraratna, Chief Scientific Officer of Io Therapeutics.Dr. Chandraratna continued, "IRX4204 is a first-in-class highly potent and specific agonist of RXR.We are hopeful that it will prove useful for treating Parkinson's disease, perhaps even for slowing its progression." Dr. Martin E. Sanders, Chairman and Chief Executive Officer of Io Therapeutics, said, "IRX4204 has been well tolerated in clinical trials in patients with various cancers.Io Therapeutics is now expanding the development program for IRX4204 … Continue reading

Posted in Parkinson's Treatment | Comments Off on Io Therapeutics, Inc. Announces Collaboration With The Michael J. Fox Foundation for Parkinson's Research for …

Biotie: UCB to license worldwide rights to tozadenant in Parkinson's disease from Biotie

Posted: Published on February 27th, 2013

BIOTIE THERAPIES CORP. STOCK EXCHANGE RELEASE 26 February 2013 at 7:00 p.m. Biotie: UCB to license worldwide rights to tozadenant in Parkinson`s disease from Biotie Novel product in development for the treatment of people living with Parkinson`s disease Biotie receives USD 20 million license fee payment Original agreement modified: Biotie to conduct phase 3 development Biotie and UCB announced today that UCB has licensed worldwide exclusive rights to Biotie`s tozadenant (SYN115), a selective inhibitor of the adenosine 2a receptor, currently in development for the treatment of Parkinson`s disease. As a result, Biotie will receive a one-time fee payment of USD 20 million from UCB. In addition, the parties have amended their original license agreement, such that Biotie will now conduct phase 3 development of tozadenant in return for additional payments from UCB relating to defined development, regulatory and commercialization milestones. "UCB is committed to improving the lives of people with Parkinson`s disease and currently provides Neupro a transdermal dopamine agonist for the symptomatic treatment of all stages of idiopathic Parkinson`s disease," said Professor Dr Iris Loew-Friedrich, Chief Medical Officer and Executive Vice President UCB. "Biotie is a valuable partner and the decision to in-license follows the positive top-line results of … Continue reading

Posted in Parkinson's Treatment | Comments Off on Biotie: UCB to license worldwide rights to tozadenant in Parkinson's disease from Biotie

'Radiotherapy is plain torture': Neon Roberts' mum stands by legal fight to prevent his brain tumour treatment

Posted: Published on February 27th, 2013

The mum who tried to stop her son from having radiotherapy to fight a brain tumour said her boy is more at risk now hes being treated. Sally Roberts, 37, went on the run with Neon, seven, last year before a court ordered him to have the treatment. Although the youngster has a survival rate of up to 82% now, Ms Roberts said she was upset by the decision to press ahead. Asked for her view on the legal battle, she told BBC Radio 5 Live's Victoria Derbyshire: "I stand by that. I'm upset that they moved forward in the way they have. "I'm having to face the side-effects from the radiation and the chemotherapy, which is devastating." Ms Roberts, a New Zealander living in Brighton, East Sussex, said "weak and fragile" Neon was "more in jeopardy now". She said: He is not able to go to school and his immune system is very much down. He is suffering from chronic fatigue, constipation, nausea, loss of appetite, weight loss, hair loss, reduction in saliva, damage to the salivary glands and poor short-term memory. But, despite the side-effects, Ms Roberts said she has been told the success rate from having the … Continue reading

Posted in MS Treatment | Comments Off on 'Radiotherapy is plain torture': Neon Roberts' mum stands by legal fight to prevent his brain tumour treatment

Neon Roberts: mother stands by legal bid to stop son receiving radiotherapy for brain tumour

Posted: Published on February 27th, 2013

"I constantly ask them about the side- effects and that is what I am most unhappy about." Asked for her view on the legal battle, she told BBC Radio 5 Live's Victoria Derbyshire: ''I stand by that. I'm upset that they moved forward in the way they have. ''I'm having to face the side-effects from the radiation and the chemotherapy, which is devastating.'' Ms Roberts, a New Zealander living in Brighton, East Sussex, said ''weak and fragile'' Neon had lost his hair and suffered weight loss, poor short-term memory and poor co-ordination. But, despite the side-effects, Ms Roberts said she has been told the success rate from having the treatment has been put at between 67 per cent and 82 per cent. She said: ''I have never doubted that he was not going to be alive at the end of this, with or without treatment. ''I just felt that he would be much better off without the treatment and providing the body with what it needs to heal, not bombarding it with radiation, which is what we are taught to avoid. ''I don't understand why we are using it in hospitals. I find it barbaric and plain torture. Needlessly, children … Continue reading

Posted in MS Treatment | Comments Off on Neon Roberts: mother stands by legal bid to stop son receiving radiotherapy for brain tumour

Tisch MS Research Center of New York Announced

Posted: Published on February 27th, 2013

Leading Research Center for Multiple Sclerosis Takes Name of Benefactors NEW YORK, Feb. 26, 2013 /PRNewswire-USNewswire/ -- The Board of Directors of the Multiple Sclerosis Research Center of New York (MSRCNY) today announced the re-naming of the institution as the Tisch MS Research Center of New York. Representing a new model of healthcare, the research center, coupled with its clinical affiliate, the International Multiple Sclerosis Management Practice (IMSMP), is the largest MS facility in the world with over 80,000 square feet at its Manhattan location and serves patients from over 45 countries and five continents. The name change, which is effective immediately, is a reflection of Bonnie and Dan Tisch's long standing support for the research center and an indication of their continued philanthropy to support the Center's mission of unraveling the mysteries of MS at both the cellular and molecular level and ultimately finding a cure. "We are truly honored and grateful for the tremendous generosity of the Tischs and this recognition of the outstanding research being conducted at our Center," stated Dr. Saud A. Sadiq, Director and Senior Research Scientist. "We are confident the Tisch MS Research Center of New York will continue to set the exemplary standard … Continue reading

Posted in MS Treatment | Comments Off on Tisch MS Research Center of New York Announced

Page 5,647«..1020..5,6465,6475,6485,649..5,6605,670..»